Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11002051 | Psychoneuroendocrinology | 2018 | 4 Pages |
Abstract
The findings confirm that acute olanzapine treatment directly reduces RER and suggest that treatment with this drug may also override central insulin-mediated reductions in food intake at the hypothalamus (while still independently favoring fatty acid oxidation). Acute central insulin similarly reduces RER, but in contrast to olanzapine, this may represent a physiologically appropriate response to reduction in food intake.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Laura N. Castellani, Jennifer Wilkin, Andrew R. Abela, Louise Benarroch, Zohra Ahasan, Celine Teo, Virginia Wilson, Chantel Kowalchuk, Adria Giacca, Gary J. Remington, Margaret K. Hahn,